The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-1-(4-(3-Morpholinopropoxy)phenyl)-3-(pyridin-2-yl)prop-2-en-1-one hydrochloride ID: ALA4522957
PubChem CID: 155543849
Max Phase: Preclinical
Molecular Formula: C21H25ClN2O3
Molecular Weight: 352.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cl.O=C(/C=C/c1ccccn1)c1ccc(OCCCN2CCOCC2)cc1
Standard InChI: InChI=1S/C21H24N2O3.ClH/c24-21(10-7-19-4-1-2-11-22-19)18-5-8-20(9-6-18)26-15-3-12-23-13-16-25-17-14-23;/h1-2,4-11H,3,12-17H2;1H/b10-7+;
Standard InChI Key: XDPSJRBXHDDQEE-HCUGZAAXSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
5.0393 -5.6914 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.3269 -3.3425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3258 -4.1621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0338 -4.5710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7435 -4.1616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7407 -3.3389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0321 -2.9337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4468 -2.9277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1561 -3.3336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8622 -2.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5715 -3.3283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5715 -4.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2799 -4.5502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9870 -4.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9813 -3.3174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2723 -2.9153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4438 -2.1105 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6178 -4.5701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9104 -4.1609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2023 -4.5690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4950 -4.1598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7869 -4.5679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0828 -4.1571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3769 -4.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3721 -5.3792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0793 -5.7905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7914 -5.3843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
6 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
8 17 2 0
3 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
22 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 352.43Molecular Weight (Monoisotopic): 352.1787AlogP: 3.08#Rotatable Bonds: 8Polar Surface Area: 51.66Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.32CX LogP: 2.61CX LogD: 2.57Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.42Np Likeness Score: -1.39
References 1. Kim HJ, Jang BK, Park JH, Choi JW, Park SJ, Byeon SR, Pae AN, Lee YS, Cheong E, Park KD.. (2020) A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model., 185 [PMID:31670201 ] [10.1016/j.ejmech.2019.111777 ]